Harbour Investments’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.5K Hold
6,521
﹤0.01% 3026
2025
Q4
$33.8K Hold
6,521
﹤0.01% 2150
2025
Q3
$27.5K Hold
6,521
﹤0.01% 2191
2025
Q2
$23.9K Hold
6,521
﹤0.01% 2161
2025
Q1
$28.2K Hold
6,521
﹤0.01% 2039
2024
Q4
$20.9K Hold
6,521
﹤0.01% 2113
2024
Q3
$18.6K Hold
6,521
﹤0.01% 2089
2024
Q2
$18.3K Buy
6,521
+1,633
+33% +$4.38K ﹤0.01% 1998
2024
Q1
$13.9K Hold
4,888
﹤0.01% 2102
2023
Q4
$20K Hold
4,888
﹤0.01% 1879
2023
Q3
$15.5K Sell
4,888
-100
-2% -$318 ﹤0.01% 1862
2023
Q2
$16.6K Hold
4,988
﹤0.01% 1830
2023
Q1
$10.6K Hold
4,988
﹤0.01% 1992
2022
Q4
$13.4K Hold
4,988
﹤0.01% 1837
2022
Q3
$24K Hold
4,988
﹤0.01% 1564
2022
Q2
$24K Buy
+4,988
New +$30.7K ﹤0.01% 1564
2021
Q4
$2K Sell
200
-617
-76% -$6.55K ﹤0.01% 2418
2021
Q3
$12K Buy
817
+617
+309% +$9.58K ﹤0.01% 2574
2021
Q2
$3K Hold
200
﹤0.01% 3263
2021
Q1
$4K Buy
+200
New +$2.71K ﹤0.01% 2999

Other funds holding ORGO

Harbour Investments's ORGO Position: Q1 2026 in Review

Harbour Investments held its Organogenesis Holdings (ORGO) position steady in Q1 2026 at 6,521 shares worth $15.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3026.

Harbour Investments first reported a position in ORGO in Q1 2021 and has held it in 20 quarters since. The position peaked at $33.8K in Q4 2025. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

  • Harbour Investments held 6,521 shares of Organogenesis Holdings worth $15.5K as of Q1 2026.
  • Harbour Investments left its Organogenesis Holdings share count unchanged in Q1 2026.
  • Organogenesis Holdings made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #3026 holding.
  • Harbour Investments first reported a position in Organogenesis Holdings in Q1 2021 and has held it in 20 quarters since.
  • Harbour Investments's Organogenesis Holdings position peaked at $33.8K in Q4 2025.
  • 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.